NICOLE LAZZARO: Open Payments
NPI 1851651889 · PRINCETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 47 payments from 18 companies in 2025. Trend: 2023 $1,117 · 2024 $1,144 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 13 | $238 |
| Organon LLC | 9 | $92 |
| Novartis Pharmaceuticals Corporation | 2 | $68 |
| Journey Medical Corporation | 2 | $49 |
| Galderma Laboratories, L.P. | 3 | $48 |
| REVANCE THERAPEUTICS, INC. | 1 | $45 |
| Fidia Pharma USA Inc. | 2 | $39 |
| Botanix SB Inc | 2 | $37 |
| Amgen Inc. | 2 | $35 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $33 |
Products named: DAXXIFY, SOFDRA, Otezla, NEMLUVIO, Winlevi, Bimzelx, ANZUPGO, VTAMA.
Industry payments across NJ — which companies pay providers there.
